
pmid: 33213162
The algorithm for dia-gnosing and treating HCC has been relatively stable for many years. In the last few years, there has been clear progress, which is reflected in the international recommendations and in our recommendations, which are set out in the Blue Book of the Czech Oncological Society.Current developments in the dia-gnosis and treatment of hepatocellular carcinoma (HCC) are well illustrated by selected presentations from this years Gastrointestinal Cancers Symposium in San Francisco and the American Society for Clinical Oncology Annual Meeting 2020. The review will focus on selected news from the dia-gnostics as well as surgical and interventional treatment of HCC, systemic treatment and a combination of these modalities.
Carcinoma, Hepatocellular, Liver Neoplasms, Humans, Prognosis, Combined Modality Therapy
Carcinoma, Hepatocellular, Liver Neoplasms, Humans, Prognosis, Combined Modality Therapy
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 12 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
